HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

Fungal Endophthalmitis

Fungal Endophthalmitis

Ongoing research and advancements in the treatment of fungal endophthalmitis aim to improve therapeutic outcomes and minimize the associated morbidity. Antifungal agents, such as voriconazole and amphotericin B, play a central role in medical management. However, the emergence of antifungal resistance poses a significant challenge, prompting exploration into novel antifungal agents and combination therapies. Intravitreal injections of antifungal medications have become a standard approach for delivering high concentrations directly to the site of infection. Research efforts focus on optimizing drug formulations and exploring sustained-release delivery systems to enhance treatment efficacy. Additionally, immunomodulatory therapies are under investigation to augment the host's immune response against fungal pathogens. Advancements in diagnostic techniques, including molecular methods and polymerase chain reaction (PCR), contribute to quicker and more accurate identification of causative fungi. This enables a targeted and personalized approach to treatment, improving the overall management of fungal endophthalmitis. Collaboration between clinicians, microbiologists, and researchers is essential to staying at the forefront of fungal endophthalmitis management. Continued exploration of innovative treatment modalities, understanding the pathogenesis of fungal infections, and implementing preventive strategies will contribute to the evolution of effective and tailored approaches for combating this challenging ocular condition.

Committee Members
Speaker at World Congress on Infectious Disease 2025 - Reza Nassiri

Reza Nassiri

Michigan State University, United States
Speaker at World Congress on Infectious Disease 2025 - Francis J Castellino

Francis J Castellino

University of Notre Dame, United States
Speaker at World Congress on Infectious Disease 2025 - Saurabh Chattopadhyay

Saurabh Chattopadhyay

University of Kentucky College of Medicine, United States
WCID 2025 Speakers
Speaker at World Congress on Infectious Disease 2025 - Johnson J H Wang

Johnson J H Wang

Wang Electro-Opto Corporation, United States
Speaker at World Congress on Infectious Disease 2025 - Victor J Alexander

Victor J Alexander

Capital Stem Cell Research Corporation, United States
Speaker at World Congress on Infectious Disease 2025 - Jacob R Miller

Jacob R Miller

Penn State University, United States
Speaker at World Congress on Infectious Disease 2025 - Anmol Grewal

Anmol Grewal

Abrazo Health, United States

Submit your abstract Today

Newsletter

By signing up, you agree to join our mailing list to receive information and updates.

Watsapp